Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance*
I. Söderström,H. Edlund,Fredrik Backlund,A. Sykaras,Pär Steneberg,Jurate Straseviçiene
DOI: https://doi.org/10.1074/jbc.M115.640292
IF: 5.485
2015-06-17
Journal of Biological Chemistry
Abstract:Background: Enhanced hepatic expression of the fatty acid transporter Cd36 correlates with liver fat accumulation, hepatosteatosis, insulin resistance, and hyperinsulinemia. Results: Insulin increases hepatic Cd36 expression in a Pparγ-dependent manner. Conclusion: Hyperinsulinemia stimulates hepatic Cd36 expression, which correlates with the development of hepatosteatosis, hepatic insulin resistance, and dysglycemia. Significance: Hyperinsulinemia contributes to the development of hepatosteatosis and insulin resistance. Hepatosteatosis is associated with the development of both hepatic insulin resistance and Type 2 diabetes. Hepatic expression of Cd36, a fatty acid transporter, is enhanced in obese and diabetic murine models and human nonalcoholic fatty liver disease, and thus it correlates with hyperinsulinemia, steatosis, and insulin resistance. Here, we have explored the effect of hyperinsulinemia on hepatic Cd36 expression, development of hepatosteatosis, insulin resistance, and dysglycemia. A 3-week sucrose-enriched diet was sufficient to provoke hyperinsulinemia, hepatosteatosis, hepatic insulin resistance, and dysglycemia in CBA/J mice. The development of hepatic steatosis and insulin resistance in CBA/J mice on a sucrose-enriched diet was paralleled by increased hepatic expression of the transcription factor Pparγ and its target gene Cd36 whereas that of genes implicated in lipogenesis, fatty acid oxidation, and VLDL secretion was unaltered. Additionally, we demonstrate that insulin, in a Pparγ-dependent manner, is sufficient to directly increase Cd36 expression in perfused livers and isolated hepatocytes. Mouse strains that display low insulin levels, i.e. C57BL6/J, and/or lack hepatic Pparγ, i.e. C3H/HeN, do not develop hepatic steatosis, insulin resistance, or dysglycemia on a sucrose-enriched diet, suggesting that elevated insulin levels, via enhanced CD36 expression, provoke fatty liver development that in turn leads to hepatic insulin resistance and dysglycemia. Thus, our data provide evidence for a direct role for hyperinsulinemia in stimulating hepatic Cd36 expression and thus the development of hepatosteatosis, hepatic insulin resistance, and dysglycemia.
Biology,Medicine